OPAT and the hospitalist : a short review on the IDSA recommendations and practice
No Thumbnail Available
Meeting name
Sponsors
Date
Journal Title
Format
Article
Abstract
Infectious Disease Society of America defines OPAT as administration of parenteral antimicrobial therapy in at least 2 doses on different days without intervening hospitalization. The first description of successful administration of OPAT was published in 1974, where the safety and efficacy of its use to treat chronic bronchopulmonary infections in children with cystic fibrosis was reported.1 OPAT has developed and passed through different refinements since then. The Infectious Disease Society of America recommends all patients should have an ID expert review prior to initiation of OPAT. This recommendation is a strong recommendation with very low-quality evidence. With the increasing burden on the ID consultation service, a valid question to answer is whether a hospitalist led OPAT management should be an option especially in short duration OPAT of a week or less. In this short review we will try to review the available data behind the recommendations of IDSA and we will also review OPAT practice in a few other countries.
Table of Contents
DOI
PubMed ID
Degree
Thesis Department
Rights
OpenAccess.
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.